It seems that pharmacotherapy is starting to catch up with bariatric surgery with regards to initial weight loss, but long-term data are still not available
these changes are thought to be related to changes in cravings, hunger and fullness (Mozafarriun et al 2025)
In multiple sclerosis (MS), a neuroinflammatory disease driven by immune-mediated destruction of myelin-producing oligodendrocytes, CYP51A1 has emerged as a potential therapeutic target
For those seeking guided peptide therapy, our experienced medical team designs personalized protocols based on clinical goals, medical history, and lab results
Baseline and periodic IGF-I , fasting glucose/HbA1c, lipids, liver function tests, and clinician-directed screening are typical
Does the serum help with both dark circles and discoloration